Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants, also known as BRIDGe.
C-Path’s TRxA launches 2024 grants to boost next-gen therapeutics
- Post author:
- Post published:January 23, 2024
- Post category:uncategorized